Just yesterday, a senior official at EMA told an Italian daily that “it is clear” that there was a link between the AstraZeneca vaccine and a rare form of blood clot, but the cause is still unknown. What’s more, there have been concerns that the risk of extremely rare blood clots could be marginally higher among younger people.
Other European countries such as Germany and the Netherlands have restricted the vaccine to those over the age of 60 and France has restricted it to those over 55. In the meantime, the UK is also advising against young people, at least those under the age of 30, taking the vaccine.
Fearne assured the public that in the coming weeks, the Johnson and Johnson vaccine would arrive on our shores. He said that even if the guidelines suggested that the vaccination programme for the AstraZeneca vaccine had to be put on hold, the country still had other vaccines available to take.